CD44v9 as a poor prognostic factor of triple-negative breast cancer treated with neoadjuvant chemotherapy
2018 · Breast Cancer · 24 citations
https://doi.org/10.1007/s12282-018-0888-y
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
9
Papers
28
Citations
2
h-index
1
i10-index
Kimiko Baba is an academic researcher from National Hospital Organization Kyushu Cancer Center. The author has contributed to research in topics: Breast Cancer Treatment Studies & Cancer Genomics and Diagnostics & DNA Repair Mechanisms. The author has an h-index of 2, co-authored 8 publications.
Click to start Chat